PLGA-based nanomedicine: history of advancement and development in clinical applications of multiple diseases

HO Alsaab, FD Alharbi, AS Alhibs, NB Alanazi… - Pharmaceutics, 2022 - mdpi.com
Research on the use of biodegradable polymers for drug delivery has been ongoing since
they were first used as bioresorbable surgical devices in the 1980s. For tissue engineering …

Recent advances in the surface functionalization of PLGA-based nanomedicines

MM El-Hammadi, JL Arias - Nanomaterials, 2022 - mdpi.com
Therapeutics are habitually characterized by short plasma half-lives and little affinity for
targeted cells. To overcome these challenges, nanoparticulate systems have entered into …

[HTML][HTML] Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's …

A Cano, M Ettcheto, JH Chang, E Barroso… - Journal of Controlled …, 2019 - Elsevier
Abstract Epigallocatechin-3-gallate (EGCG) is a candidate for treatment of Alzheimer's
disease (AD) but its inherent instability limits bioavailability and effectiveness. We found that …

Chitosan-modified PLGA nanoparticles for control-released drug delivery

B Lu, X Lv, Y Le - Polymers, 2019 - mdpi.com
Poly (lactic-co-glycolic acid) nanoparticles (PLGA NPs) are well recognized as an ideal drug
delivery carrier for their biocompatibility and biodegradability. In order to overcome the …

The synthesis and characterization of double nanoemulsion for targeted Co-Delivery of 5-fluorouracil and curcumin using pH-sensitive agarose/chitosan nanocarrier

M Pourmadadi, M Ahmadi, M Abdouss… - Journal of Drug Delivery …, 2022 - Elsevier
Due to the dangerous side effects of chemotherapy, advanced methods for curing cancer,
such as drug delivery, have attracted much attention because of their high efficacies. Using …

Engineering nanosystems to overcome barriers to cancer diagnosis and treatment

SO Alhaj-Suliman, EI Wafa, AK Salem - Advanced drug delivery reviews, 2022 - Elsevier
Over the past two decades, multidisciplinary investigations into the development of
nanoparticles for medical applications have continually increased. However, nanoparticles …

Targeting cancer stem cells to overcome chemoresistance

T Nunes, D Hamdan, C Leboeuf… - International journal of …, 2018 - mdpi.com
Cancers are heterogeneous at the cell level, and the mechanisms leading to cancer
heterogeneity could be clonal evolution or cancer stem cells. Cancer stem cells are resistant …

The recent advancement in the PLGA-based thermo-sensitive hydrogel for smart drug delivery

F Rahmani, R Atabaki, S Behrouzi… - International Journal of …, 2023 - Elsevier
To date, hydrogels have opened new prospects for potential applications for drug delivery.
The thermo-sensitive hydrogels have the great potential to provide more effective and …

[HTML][HTML] A novel 5-Fluorouracil targeted delivery to colon cancer using folic acid conjugated liposomes

S Handali, E Moghimipour, M Rezaei… - Biomedicine & …, 2018 - Elsevier
The aim of this study was to develop and characterize 5-Fluorouracil (5FU) containing
targeted liposomes in order to enhance the efficacy and safety of the drug. Folic acid (FA) …

Recent advances in folic acid engineered nanocarriers for treatment of breast cancer

P Tagde, GT Kulkarni, DK Mishra… - Journal of Drug Delivery …, 2020 - Elsevier
Breast cancer is one of the most prevalent types of cancer among female patients, which is
caused by mutations in the oestrogen/progesterone receptors. Conventional treatment …